August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Dana responded well to the experimental drug nirogacestat for her desmoid tumor – Memorial Sloan Kettering Cancer Center
Dec 7, 2023, 03:21

Dana responded well to the experimental drug nirogacestat for her desmoid tumor – Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center shared on their LinkedIn:

“ICYMI: On November 27, the U.S. Food and Drug Administration approved nirogacestat (Ogsiveo™) for adults with desmoid tumors that cannot be treated with surgery alone. The approval was based on research led by investigators at MSK. Nirogacestat is the first targeted therapy ever to be approved for desmoid tumors.

Dana, shown here with her husband, John, has responded well to the experimental drug nirogacestat for her desmoid tumor. Learn more about her care from MSK’s sarcoma expert Mrinal Gounder here. ”

Source: Memorial Sloan Kettering Cancer Center/LinkedIn